Literature DB >> 16308682

The intensive care support of patients with malignancy: do everything that can be done.

Elie Azoulay, Bekele Afessa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16308682     DOI: 10.1007/s00134-005-2835-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  27 in total

1.  Consider saying yes.

Authors:  Jeffrey S Groeger; Peter B Bach
Journal:  Crit Care Med       Date:  2003-01       Impact factor: 7.598

2.  Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit.

Authors:  Dominique D Benoit; Pieter O Depuydt; Koenraad H Vandewoude; Fritz C Offner; Tom Boterberg; Carole A De Cock; Lucien A Noens; Ann M Janssens; Johan M Decruyenaere
Journal:  Intensive Care Med       Date:  2005-11-25       Impact factor: 17.440

3.  Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients.

Authors:  Bekele Afessa; Ayalew Tefferi; Mark R Litzow; Steve G Peters
Journal:  Am J Respir Crit Care Med       Date:  2002-09-25       Impact factor: 21.405

4.  Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study.

Authors:  Guillaume Thiéry; Elie Azoulay; Michael Darmon; Magali Ciroldi; Sandra De Miranda; Vincent Lévy; Fabienne Fieux; Delphine Moreau; Jean Roger Le Gall; Benoît Schlemmer
Journal:  J Clin Oncol       Date:  2005-07-01       Impact factor: 44.544

5.  Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy.

Authors:  Michael Darmon; Guillaume Thiery; Magali Ciroldi; Sandra de Miranda; Lionel Galicier; Emmanuel Raffoux; Jean-Roger Le Gall; Benoît Schlemmer; Elie Azoulay
Journal:  Crit Care Med       Date:  2005-11       Impact factor: 7.598

6.  Outcomes of critically ill cancer patients in a university hospital setting.

Authors:  J P Kress; J Christenson; A S Pohlman; D R Linkin; J B Hall
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

7.  The prognosis of acute respiratory failure in critically ill cancer patients.

Authors:  Élie Azoulay; Guillaume Thiéry; Sylvie Chevret; Delphine Moreau; Michaël Darmon; Anne Bergeron; Kun Yang; Véronique Meignin; Magali Ciroldi; Jean-Roger Le Gall; Abdellatif Tazi; Benoît Schlemmer
Journal:  Medicine (Baltimore)       Date:  2004-11       Impact factor: 1.889

8.  Outcome in noninvasively and invasively ventilated hematologic patients with acute respiratory failure.

Authors:  Pieter O Depuydt; Dominique D Benoit; Koenraad H Vandewoude; Johan M Decruyenaere; Francis A Colardyn
Journal:  Chest       Date:  2004-10       Impact factor: 9.410

9.  Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines.

Authors:  G D Rubenfeld; S W Crawford
Journal:  Ann Intern Med       Date:  1996-10-15       Impact factor: 25.391

10.  Improved survival of critically ill cancer patients with septic shock.

Authors:  Jérôme Larché; Elie Azoulay; Fabienne Fieux; Laurent Mesnard; Delphine Moreau; Guillaume Thiery; Michaël Darmon; Jean-Roger Le Gall; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2003-09-12       Impact factor: 17.440

View more
  44 in total

Review 1.  Year in Review in Intensive Care Medicine, 2006. III. Circulation, ethics, cancer, outcome, education, nutrition, and pediatric and neonatal critical care.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Daniel De Backer; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Duncan Macrae; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerôme Pugin; Michael Pinsky; Peter Radermacher; Christian Richard
Journal:  Intensive Care Med       Date:  2007-02-14       Impact factor: 17.440

2.  Early intervention on the outcomes in critically ill cancer patients admitted to intensive care units.

Authors:  Jae-Uk Song; Gee Young Suh; Hye Yun Park; So Yeon Lim; Seo Goo Han; Yeh Rim Kang; O Jung Kwon; Sookyoung Woo; Kyeongman Jeon
Journal:  Intensive Care Med       Date:  2012-05-17       Impact factor: 17.440

3.  Critical care management of lung cancer patients to prolong life without prolonging dying.

Authors:  Márcio Soares; Elie Azoulay
Journal:  Intensive Care Med       Date:  2009-09-19       Impact factor: 17.440

4.  [The oncology patient in intensive care].

Authors:  M Kochanek; T Staudinger
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-04       Impact factor: 0.840

5.  Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients.

Authors:  Yu Jung Kim; Mi-Jung Kim; Young-Jae Cho; Jong Sun Park; Jin Won Kim; Hyun Chang; Jeong-Ok Lee; Keun-Wook Lee; Jee Hyun Kim; Ho Il Yoon; Soo-Mee Bang; Jae Ho Lee; Choon-Taek Lee; Jong Seok Lee
Journal:  Med Oncol       Date:  2014-01-22       Impact factor: 3.064

6.  Should age be a criterion for intensive care unit admission in cancer patients?-Still an issue of uncertainty.

Authors:  Maria Daganou; Anna Kyriakoudi; Antonia Koutsoukou
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

7.  My paper 20 years later: NIV in immunocompromized patients.

Authors:  Gilles Hilbert; Frédéric Vargas
Journal:  Intensive Care Med       Date:  2018-04-05       Impact factor: 17.440

Review 8.  [Extracorporeal membrane oxygenation : System selection, (contra)indications, and management].

Authors:  T Staudinger
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-05       Impact factor: 0.840

9.  Continued survival gains in recent years among critically ill myeloma patients.

Authors:  Vincent Peigne; Katerina Rusinová; Lionel Karlin; Michael Darmon; Jean-Paul Fermand; Benoît Schlemmer; Elie Azoulay
Journal:  Intensive Care Med       Date:  2008-10-14       Impact factor: 17.440

Review 10.  [Chronic critically ill patients from the perspective of hematologists/oncologists].

Authors:  T Staudinger; P Schellongowski
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-02-28       Impact factor: 0.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.